APO RESEARCH · REPORT
Glabridin
Glabridin is a chemical compound that is found in the root extract of licorice (Glycyrrhiza glabra). Glabridin is an isoflavane, a type of isoflavonoid. This product is part of a larger family of plant-derived molecules, the natural phenols. Glabridin is yellowish-brown powder. It is insoluble in water, but soluble in organic solvents such as propylene glycol.
Product & engineering
Understand the product.
Glabridin is a chemical compound that is found in the root extract of licorice (Glycyrrhiza glabra). Glabridin is an isoflavane, a type of isoflavonoid. This product is part of a larger family of plant-derived molecules, the natural phenols. Glabridin is yellowish-brown powder. It is insoluble in water, but soluble in organic solvents such as propylene glycol.
Selected research
Market Structure
Global Glabridin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Glabridin is a chemical compound that is found in the root extract of licorice (Glycyrrhiza glabra). Glabridin is an isoflavane, a type of isoflavonoid. This product is part of a larger family of plant-derived molecules, the natural phenols. Glabridin is yellowish-brown powder. It is insoluble in water, but soluble in organic solvents such as propylene glycol.
Global Glabridin market can be divided into 20% (HPLC), 40% (HPLC), 60% (HPLC), 90% (HPLC), 98% (HPLC) and Others according to the content of active ingredients. Among them, 40% (HPLC) is the most widely used. Glabridin 40% (HPLC) was estimated to account for a revenue share of 43.54% in 2020. In 2020, Glabridin 40% (HPLC) segment is estimated to be valued at 7778 K USD which is expected to reach at 10718 K USD in 2026, with a CAGR of 5.49% over the forecast period.
Global Glabridin Application segment consists of Cosmetic and Pharmaceutical. Cosmetic was estimated to account for a sales share of 89.17% in 2020. In 2020, the Cosmetic segment is estimated to sale at 2086 Kg which is expected to reach at 2685 Kg in 2026, with a CAGR of 4.29% over the forecast period.This report focuses on the Glabridin in global market, especially in North America, Europe, China, India and Japan. As the largest producer, China produced 949 Kg of Glabridin in 2019, accounting for 37.85% of the global total. The United States is the most important consumer country, with consumption accounting for 24.28% of the global in 2019.
Read the full market overview
The report provides an overview of the global Glabridin market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Glabridin and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Glabridin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glabridin market size, projected growth trends, production technologies, key applications, and end-use industries.
Glabridin Segment by Company
Sabinsa
Alchem International
MAFCO
Plamed Green Science Group
Xi'an Zhongying
Spring Autumn Biological
Huaian Brothers Biotechnology
Xi’an Tianye Biotech
Maruzen Pharmaceuticals
SK Bioland
Sunpure Extracts
Glabridin Segment by Type
20% (HPLC)
40% (HPLC)
60% (HPLC)
90% (HPLC)
98% (HPLC)
Other
Glabridin Segment by Application
Cosmetic
Pharmaceutical
Glabridin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glabridin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glabridin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glabridin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Glabridin market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glabridin industry.
Chapter 3: Detailed analysis of Glabridin market competition landscape. Including Glabridin manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Glabridin by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Glabridin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 20% (HPLC)
- 40% (HPLC)
- 60% (HPLC)
- 90% (HPLC)
- 98% (HPLC)
- Other
Applications
- Cosmetic
- Pharmaceutical
Companies covered
- Sabinsa
- Alchem International
- MAFCO
- Plamed Green Science Group
- Xi'an Zhongying
- Spring Autumn Biological
- Huaian Brothers Biotechnology
- Xi’an Tianye Biotech
- Maruzen Pharmaceuticals
- SK Bioland
- Sunpure Extracts
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Glabridin Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Glabridin Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Glabridin Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Glabridin Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Glabridin Market Dynamics
- 2.1 Glabridin Industry Trends
- 2.2 Glabridin Industry Drivers
- 2.3 Glabridin Industry Opportunities and Challenges
- 2.4 Glabridin Industry Restraints
3 Glabridin Market by Manufacturers
- 3.1 Global Glabridin Production Value by Manufacturers (2021-2026)
- 3.2 Global Glabridin Production by Manufacturers (2021-2026)
- 3.3 Global Glabridin Average Price by Manufacturers (2021-2026)
- 3.4 Global Glabridin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Glabridin Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Glabridin Manufacturers, Product Type & Application
- 3.7 Global Glabridin Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Glabridin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Glabridin Players Market Share by Production Value in 2025
- 3.8.3 2025 Glabridin Tier 1, Tier 2, and Tier 3
4 Glabridin Market by Type
- 4.1 Glabridin Type Introduction
- 4.1.1 20% (HPLC)
- 4.1.2 40% (HPLC)
- 4.1.3 60% (HPLC)
- 4.1.4 90% (HPLC)
- 4.1.5 98% (HPLC)
- 4.1.6 Other
- 4.2 Global Glabridin Production by Type
- 4.2.1 Global Glabridin Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Glabridin Production by Type (2021-2032)
- 4.2.3 Global Glabridin Production Market Share by Type (2021-2032)
- 4.3 Global Glabridin Production Value by Type
- 4.3.1 Global Glabridin Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Glabridin Production Value by Type (2021-2032)
- 4.3.3 Global Glabridin Production Value Market Share by Type (2021-2032)
5 Glabridin Market by Application
- 5.1 Glabridin Application Introduction
- 5.1.1 Cosmetic
- 5.1.2 Pharmaceutical
- 5.2 Global Glabridin Production by Application
- 5.2.1 Global Glabridin Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Glabridin Production by Application (2021-2032)
- 5.2.3 Global Glabridin Production Market Share by Application (2021-2032)
- 5.3 Global Glabridin Production Value by Application
- 5.3.1 Global Glabridin Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Glabridin Production Value by Application (2021-2032)
- 5.3.3 Global Glabridin Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Sabinsa
- 6.1.1 Sabinsa Company Information
- 6.1.2 Sabinsa Business Overview
- 6.1.3 Sabinsa Glabridin Production, Value and Gross Margin (2021-2026)
- 6.1.4 Sabinsa Glabridin Product Portfolio
- 6.1.5 Sabinsa Recent Developments
- 6.2 Alchem International
- 6.2.1 Alchem International Company Information
- 6.2.2 Alchem International Business Overview
- 6.2.3 Alchem International Glabridin Production, Value and Gross Margin (2021-2026)
- 6.2.4 Alchem International Glabridin Product Portfolio
- 6.2.5 Alchem International Recent Developments
- 6.3 MAFCO
- 6.3.1 MAFCO Company Information
- 6.3.2 MAFCO Business Overview
- 6.3.3 MAFCO Glabridin Production, Value and Gross Margin (2021-2026)
- 6.3.4 MAFCO Glabridin Product Portfolio
- 6.3.5 MAFCO Recent Developments
- 6.4 Plamed Green Science Group
- 6.4.1 Plamed Green Science Group Company Information
- 6.4.2 Plamed Green Science Group Business Overview
- 6.4.3 Plamed Green Science Group Glabridin Production, Value and Gross Margin (2021-2026)
- 6.4.4 Plamed Green Science Group Glabridin Product Portfolio
- 6.4.5 Plamed Green Science Group Recent Developments
- 6.5 Xi'an Zhongying
- 6.5.1 Xi'an Zhongying Company Information
- 6.5.2 Xi'an Zhongying Business Overview
- 6.5.3 Xi'an Zhongying Glabridin Production, Value and Gross Margin (2021-2026)
- 6.5.4 Xi'an Zhongying Glabridin Product Portfolio
- 6.5.5 Xi'an Zhongying Recent Developments
- 6.6 Spring Autumn Biological
- 6.6.1 Spring Autumn Biological Company Information
- 6.6.2 Spring Autumn Biological Business Overview
- 6.6.3 Spring Autumn Biological Glabridin Production, Value and Gross Margin (2021-2026)
- 6.6.4 Spring Autumn Biological Glabridin Product Portfolio
- 6.6.5 Spring Autumn Biological Recent Developments
- 6.7 Huaian Brothers Biotechnology
- 6.7.1 Huaian Brothers Biotechnology Company Information
- 6.7.2 Huaian Brothers Biotechnology Business Overview
- 6.7.3 Huaian Brothers Biotechnology Glabridin Production, Value and Gross Margin (2021-2026)
- 6.7.4 Huaian Brothers Biotechnology Glabridin Product Portfolio
- 6.7.5 Huaian Brothers Biotechnology Recent Developments
- 6.8 Xi’an Tianye Biotech
- 6.8.1 Xi’an Tianye Biotech Company Information
- 6.8.2 Xi’an Tianye Biotech Business Overview
- 6.8.3 Xi’an Tianye Biotech Glabridin Production, Value and Gross Margin (2021-2026)
- 6.8.4 Xi’an Tianye Biotech Glabridin Product Portfolio
- 6.8.5 Xi’an Tianye Biotech Recent Developments
- 6.9 Maruzen Pharmaceuticals
- 6.9.1 Maruzen Pharmaceuticals Company Information
- 6.9.2 Maruzen Pharmaceuticals Business Overview
- 6.9.3 Maruzen Pharmaceuticals Glabridin Production, Value and Gross Margin (2021-2026)
- 6.9.4 Maruzen Pharmaceuticals Glabridin Product Portfolio
- 6.9.5 Maruzen Pharmaceuticals Recent Developments
- 6.10 SK Bioland
- 6.10.1 SK Bioland Company Information
- 6.10.2 SK Bioland Business Overview
- 6.10.3 SK Bioland Glabridin Production, Value and Gross Margin (2021-2026)
- 6.10.4 SK Bioland Glabridin Product Portfolio
- 6.10.5 SK Bioland Recent Developments
- 6.11 Sunpure Extracts
- 6.11.1 Sunpure Extracts Company Information
- 6.11.2 Sunpure Extracts Business Overview
- 6.11.3 Sunpure Extracts Glabridin Production, Value and Gross Margin (2021-2026)
- 6.11.4 Sunpure Extracts Glabridin Product Portfolio
- 6.11.5 Sunpure Extracts Recent Developments
7 Global Glabridin Production by Region
- 7.1 Global Glabridin Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Glabridin Production by Region (2021-2032)
- 7.2.1 Global Glabridin Production by Region (2021-2026)
- 7.2.2 Global Glabridin Production Forecast by Region (2027-2032)
- 7.3 Global Glabridin Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Glabridin Production Value by Region (2021-2032)
- 7.4.1 Global Glabridin Production Value by Region (2021-2026)
- 7.4.2 Global Glabridin Production Value by Region (2027-2032)
- 7.5 Global Glabridin Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Glabridin Production Value (2021-2032)
- 7.6.2 Europe Glabridin Production Value (2021-2032)
- 7.6.3 Asia-Pacific Glabridin Production Value (2021-2032)
- 7.6.4 South America Glabridin Production Value (2021-2032)
- 7.6.5 Middle East & Africa Glabridin Production Value (2021-2032)
8 Global Glabridin Consumption by Region
- 8.1 Global Glabridin Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Glabridin Consumption by Region (2021-2032)
- 8.2.1 Global Glabridin Consumption by Region (2021-2026)
- 8.2.2 Global Glabridin Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Glabridin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Glabridin Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Glabridin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Glabridin Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Glabridin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Glabridin Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Glabridin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Glabridin Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Glabridin Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Glabridin Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Glabridin Value Chain Analysis
- 9.1.1 Glabridin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Glabridin Production Mode & Process
- 9.2 Glabridin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Glabridin Distributors
- 9.2.3 Glabridin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst